The Impact of National Pricing and Reimbursement Practices on Prices and Availability of Medicines in Other Countries
This chapter examines the transnational impact of national pricing and reimbursement policies. Pharmaceutical pricing policies, and their impacts on prices and availability of medicines, are becoming more exportable in a globalised market. This chapter documents these and assesses the extent of their transnational effects. The various strategies that manufacturers in a globalised pharmaceutical market use in response to national pricing policies are also examined. Finally, the extent to which pricing policies and manufacturers' strategies have led to convergence among countries in pharmaceutical prices is assessed.
No Supplementary Data
Document Type: Review Article
Publication date: 2008-09-01